Standard Chartered (HKG:2888) repurchased 773,000 shares on Thursday at an average price of 19.33 pounds sterling apiece, according to a Friday filing with the Hong Kong bourse.
The British lender plans to cancel the shares, following which it will have about 2.21 billion shares in issue.
Shanghai Henlius Biotech (HKG:2696) dosed the first patient in a Phase 1 clinical trial of HLX316 for injection, according to a Friday Hong Kong bourse filing.The trial is studying the effects of the drug in patients with advanced/metastatic solid tumors in Mainland China.
The Hour Glass' (SGX:AGS) attributable profit to owners surged 39% during the fiscal second half ended March 31 to SG$103.7 million from SG$74.4 million a year earlier, according to a Friday filing with the Singapore Exchange.Earnings per share came in at SG$0.1610 compared with SG$0.1148 in the year-ago period.The luxury watch retailer's revenue jumped 16% year over year to SG$772.8 million from SG$622.6 million.The company recommended a final dividend of SG$0.04 per share and an interim dividend of SG$0.02 per share.
NEC Capital Solutions (TYO:8793) plans to issue its 32nd and 33rd unsecured bond series, each totalling 12 billion yen, according to a Tokyo bourse filing on Friday.The 32nd bonds carry an interest rate of 2.086% with a maturity date of May 28, 2029, while the 33rd bonds bear a 2.567% rate and mature on May 28, 2031.Both series are unsecured, have a face value of 100 million yen per bond, and will be issued at par with redemption also at par.The bonds received credit ratings of A from Japan Credit Rating Agency and A- from Rating & Investment Information, with payment scheduled for May 28.